Thank you for this website. It has been very helpful for me. I was diagnosed in Chronic phase last November with a BCR of 96% and began treatment Nov 17 on Imatinib. At my 3 month check I was at 15%. We did not switch but checked again at 4 1/2 months and I was at 5.1%. Now at the 6 month check I am at 3%.
Aside from a rash, the side effects have subsided and I am tolerating Imatinib well. But this response seems slower than the standard. I see my Oncologist tomorrow and will see what she thinks. Initially we debated between Imatinib and Dasatinib, but went with Imatinib.
Since I didn't get to under 1% by the 6 month mark would you consider a switch or would you stay the current course?